The increased levels of plasma IL-33 indicate that IL-33 measurement in HIV-1 monoinfected patients can be a potential surrogate marker of immune activation in the context of HIV-TB coinfection in a resource-limited setting. This evidence concerns the gene IL33 and coinfection.